/PRNewswire/ Curebase, a company committed to democratizing access to clinical studies and a leader in decentralized clinical trial (DCT) execution, is now.
/PRNewswire/ Curebase, a company committed to democratizing access to clinical studies, announced today that it has been named among Y Combinator s 2023 Top.
/PRNewswire/ Curebase, a company committed to democratizing access to clinical studies, capped off a successful 2022 with continued growth, maturity, and.
/PRNewswire/ Curebase, a company dedicated to democratizing clinical trials through a decentralized model is announcing its partnership with Redenlab, a.